We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNW
326
PUT
DELISTED
Light & Wonder
LNW
| $1.29M | 0.06% |
65,000
+20,000
| +44% | +$414K |
|
327
CALL
TG Therapeutics
TGTX
$7.96B
| $1.29M | 0.06% |
+149,000
| New | +$1.13M |
|
328
PUT
Incyte
INCY
$24.2B
| $1.27M | 0.06% |
+15,000
| New | +$1.2M |
|
329
Caesars Entertainment
CZR
$6.06B
| $1.27M | 0.06% |
+27,600
| New | +$1.35M |
|
|
RDUS
330
CALL
DELISTED
Radius Health, Inc.
RDUS
| $1.27M | 0.06% |
52,200
-50,000
| -49% | -$1.09M |
|
331
CALL
Southwest Airlines
LUV
$22B
| $1.27M | 0.06% |
25,000
-175,000
| -88% | -$9.07M |
|
332
PUT
Avis
CAR
$4.86B
| $1.27M | 0.06% |
36,000
-190,000
| -84% | -$6.38M |
|
|
I
333
PUT
DELISTED
INTELSAT S. A.
I
| $1.26M | 0.06% |
+65,000
| New | +$1.26M |
|
|
ACB
334
CALL
Aurora Cannabis
ACB
$173M
| $1.25M | 0.06% |
1,333
-5,009
| -79% | -$5.03M |
|
|
ENDP
335
CALL
DELISTED
Endo International plc
ENDP
| $1.24M | 0.06% |
300,000
-100,000
| -25% | -$631K |
|
|
UNIT
336
CALL
Uniti Group
UNIT
$2.36B
| $1.24M | 0.06% |
130,000
-420,000
| -76% | -$4.59M |
|
|
SGEN
337
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.21M | 0.06% |
17,500
-60,800
| -78% | -$4.26M |
|
338
PUT
GoPro
GPRO
$130M
| $1.2M | 0.06% |
220,000
| – | – |
|
339
Conagra Brands
CAG
$6.94B
| $1.19M | 0.06% |
+45,000
| New | +$1.31M |
|
340
CryoPort
CYRX
$761M
| $1.19M | 0.06% |
+65,000
| New | +$1.03M |
|
|
HIBB
341
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.17M | 0.06% |
+64,000
| New | +$1.34M |
|
|
BBBY
342
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.16M | 0.06% |
+100,000
| New | +$1.48M |
|
343
PUT
PBF Energy
PBF
$8.57B
| $1.16M | 0.06% |
+37,000
| New | +$1.1M |
|
|
MRTX
344
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.15M | 0.06% |
+11,200
| New | +$872K |
|
|
PEGI
345
CALL
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $1.15M | 0.06% |
50,000
| – | – |
|
346
CALL
MacroGenics
MGNX
$235M
| $1.14M | 0.06% |
66,900
| – | – |
|
347
CALL
Mattel
MAT
$4.38B
| $1.12M | 0.06% |
+100,000
| New | +$1.17M |
|
|
348
PUT
Mattel
MAT
$4.38B
| $1.12M | 0.06% |
+100,000
| New | +$1.17M |
|
349
Howmet Aerospace
HWM
$113B
| $1.11M | 0.06% |
+56,333
| New | +$951K |
|
350
Spotify
SPOT
$103B
| $1.11M | 0.06% |
+7,600
| New | +$1.05M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.